Applied Therapeutics, Inc. Operating Expenses
Applied Therapeutics, Inc. reported Operating Expenses of $17.76 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-11-13
- Applied Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $17.76M, a 40.54% decline year-over-year.
- Applied Therapeutics, Inc. operating expenses for the quarter ending 2025-06-30 was $23.10M, a 12.21% increase year-over-year.
- Applied Therapeutics, Inc. operating expenses for the quarter ending 2025-03-31 was $25.52M, a 19.93% increase year-over-year.
- Applied Therapeutics, Inc. operating expenses for the quarter ending 2024-12-31 was $33.02M, a 62.34% increase year-over-year.
- Applied Therapeutics, Inc. operating expenses for fiscal 2024 was $104.75M, a 40.56% increase from fiscal 2023.
- Applied Therapeutics, Inc. operating expenses for fiscal 2023 was $74.53M, a 10.15% decline from fiscal 2022.
- Applied Therapeutics, Inc. operating expenses for fiscal 2022 was $82.95M, a 21.46% decline from fiscal 2021.
- Applied Therapeutics, Inc. operating expenses for fiscal 2021 was $105.62M, a 11.81% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2025-09-30 | $17.76M 10-Q · filed 2025-11-13 | $40.86M derived: sum of 2 quarters · filed 2025-11-13 | $66.38M 10-Q · filed 2025-11-13 | $99.40M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $23.10M 10-Q · filed 2025-08-13 | $48.62M 10-Q · filed 2025-08-13 | $81.64M derived: sum of 3 quarters · filed 2025-08-13 | $111.51M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $25.52M 10-Q · filed 2025-05-14 | $58.55M derived: sum of 2 quarters · filed 2025-05-14 | $88.41M derived: sum of 3 quarters · filed 2025-11-13 | $109.00M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $33.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $62.89M derived: sum of 2 quarters · filed 2025-11-13 | $83.47M derived: sum of 3 quarters · filed 2025-11-13 | $104.75M 10-K · filed 2025-04-15 |
| 2024-09-30 | $29.86M 10-Q · filed 2025-11-13 | $50.45M derived: sum of 2 quarters · filed 2025-11-13 | $71.73M 10-Q · filed 2025-11-13 | $92.07M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $20.58M 10-Q · filed 2025-08-13 | $41.87M 10-Q · filed 2025-08-13 | $62.21M derived: sum of 3 quarters · filed 2025-08-13 | $77.70M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $21.28M 10-Q · filed 2024-05-09 | $41.62M derived: sum of 2 quarters · filed 2025-04-15 | $57.12M derived: sum of 3 quarters · filed 2025-04-15 | $74.30M derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | $20.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $35.84M derived: sum of 2 quarters · filed 2025-04-15 | $53.01M derived: sum of 3 quarters · filed 2025-04-15 | $74.53M 10-K · filed 2025-04-15 |
| 2023-09-30 | $15.49M 10-Q · filed 2024-11-07 | $32.67M derived: sum of 2 quarters · filed 2024-11-07 | $54.19M 10-Q · filed 2024-11-07 | $73.16M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $17.18M 10-Q · filed 2024-08-07 | $38.69M 10-Q · filed 2024-08-07 | $57.67M derived: sum of 3 quarters · filed 2024-08-07 | $77.02M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $21.52M 10-Q · filed 2024-05-09 | $40.49M derived: sum of 2 quarters · filed 2024-05-09 | $59.85M derived: sum of 3 quarters · filed 2024-05-09 | $81.37M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $18.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $38.33M derived: sum of 2 quarters · filed 2024-03-06 | $59.85M derived: sum of 3 quarters · filed 2024-03-06 | $82.95M 10-K · filed 2024-03-06 |
| 2022-09-30 | $19.36M 10-Q · filed 2023-11-09 | $40.88M derived: sum of 2 quarters · filed 2023-11-09 | $63.98M 10-Q · filed 2023-11-09 | $91.09M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $21.52M 10-Q · filed 2023-08-10 | $44.62M 10-Q · filed 2023-08-10 | $71.74M derived: sum of 3 quarters · filed 2023-08-10 | $100.17M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $23.10M 10-Q · filed 2023-05-11 | $50.22M derived: sum of 2 quarters · filed 2023-05-11 | $78.64M derived: sum of 3 quarters · filed 2023-05-11 | $104.52M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $27.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $55.54M derived: sum of 2 quarters · filed 2023-03-23 | $81.42M derived: sum of 3 quarters · filed 2023-03-23 | $105.62M 10-K · filed 2023-03-23 |
| 2021-09-30 | $28.43M 10-Q · filed 2022-11-09 | $54.30M derived: sum of 2 quarters · filed 2022-11-09 | $78.50M 10-Q · filed 2022-11-09 | $102.25M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $25.88M 10-Q · filed 2022-08-12 | $50.07M 10-Q · filed 2022-08-12 | $73.82M derived: sum of 3 quarters · filed 2022-08-12 | $103.79M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $24.20M 10-Q · filed 2022-05-12 | $47.95M derived: sum of 2 quarters · filed 2022-05-12 | $77.91M derived: sum of 3 quarters · filed 2022-05-12 | $106.19M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $23.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $53.71M derived: sum of 2 quarters · filed 2022-03-10 | $81.99M derived: sum of 3 quarters · filed 2022-03-10 | $94.47M 10-K · filed 2022-03-10 |
| 2020-09-30 | $29.96M 10-Q · filed 2021-11-12 | $58.24M derived: sum of 2 quarters · filed 2021-11-12 | $70.72M 10-Q · filed 2021-11-12 | $88.38M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $28.28M 10-Q · filed 2021-08-12 | $40.75M 10-Q · filed 2021-08-12 | $58.42M derived: sum of 3 quarters · filed 2021-08-12 | $69.16M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $12.47M 10-Q · filed 2021-05-11 | $30.14M derived: sum of 2 quarters · filed 2021-05-11 | $40.88M derived: sum of 3 quarters · filed 2021-05-11 | $49.32M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $17.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $28.42M derived: sum of 2 quarters · filed 2021-03-18 | $36.85M derived: sum of 3 quarters · filed 2021-03-18 | $45.58M 10-K · filed 2021-03-18 |
| 2019-09-30 | $10.75M 10-Q · filed 2020-11-12 | $19.18M derived: sum of 2 quarters · filed 2020-11-12 | $27.91M 10-Q · filed 2020-11-12 | $33.90M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $8.44M 10-Q · filed 2020-08-11 | $17.16M 10-Q · filed 2020-08-11 | $23.16M derived: sum of 3 quarters · filed 2020-08-11 | $26.48M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $8.73M 10-Q · filed 2020-05-11 | $14.72M derived: sum of 2 quarters · filed 2020-05-11 | $18.04M derived: sum of 3 quarters · filed 2020-05-11 | $20.38M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $9.31M derived: sum of 2 quarters · filed 2020-03-13 | $11.65M derived: sum of 3 quarters · filed 2020-03-13 | $13.52M 10-K · filed 2020-03-13 |
| 2018-09-30 | $3.32M 10-Q · filed 2019-11-13 | $5.66M derived: sum of 2 quarters · filed 2019-11-13 | $7.53M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $2.34M 10-Q · filed 2019-08-12 | $4.21M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $1.87M 10-Q · filed 2019-06-21 |